Upcoming and recently listed Biotech IPOs currently tracked by DiscoverIPO.
DiscoverIPO is tracking 23 upcoming IPOs in the Biotech. The soonest expected date currently on record is Nov 2, 2026. Listings span 3 exchanges: OTHER, LSE, JPX. Every row links to the original filing it came from, and this page updates automatically as new filings arrive.
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
| Company | Industry | Country | Price range | Offer size | Expected | Status | Source |
|---|---|---|---|---|---|---|---|
| ADDvise Group AB (publ) | Biotech | Sweden | terms not yet disclosed | Not yet set | Approved | ESMA | |
| Alopexx, Inc. | Biological Products, (No Diagnostic Substances) | United States | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
| Apolea holding AB | Biotech | Sweden | terms not yet disclosed | Not yet set | Approved | ESMA | |
| Asker Healthcare Group AB | Biotech | Sweden | terms not yet disclosed | Not yet set | Approved | ESMA | |
| BirchBioMed Inc. | Pharmaceutical Preparations | Canada | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
| Brainlab AG | Biotech | Germany | terms not yet disclosed | Not yet set | Approved | ESMA | |
| Carasent AB (publ) | Biotech | Sweden | terms not yet disclosed | Not yet set | Approved | ESMA | |
| Diagnostyka Spółka Akcyjna | Biotech | Poland | terms not yet disclosed | Not yet set | Approved | ESMA | |
| EDX Medical Group PLC | Biotech | — | terms not yet disclosed | Not yet set | Announced | FCA NSM | |
| Elements Ventures Group Inc. | Services-Misc Health & Allied Services, NEC | Canada | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
| Ionetix Corp / DE / | In Vitro & In Vivo Diagnostic Substances | United States | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
| LYC Healthcare (Cayman) LtdCAYMAN | Services-Offices & Clinics of Doctors of Medicine | Singapore | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
| MabGenesis Inc. | Biotech | Japan | terms not yet disclosed | Nov 2, 2026 | Filed with SEC | EDINET | |
| NanoEcho AB (publ) | Biotech | Sweden | terms not yet disclosed | Not yet set | Approved | ESMA | |
| Neuro Spectrum Insights, Inc. | Surgical & Medical Instruments & Apparatus | United States | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
| NuvOx Therapeutics, Inc.NUOX | Pharmaceutical Preparations | United States | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
| Ottobock SE & Co. KGaA | Biotech | Germany | terms not yet disclosed | Not yet set | Approved | ESMA | |
| Pentixapharm Holding AG | Biotech | Germany | terms not yet disclosed | Not yet set | Approved | ESMA | |
| Regenlab USA Inc.RGNA | Pharmaceutical Preparations | United States | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
| Starton Holdings, Inc.STA | Pharmaceutical Preparations | United States | terms not yet disclosed | Nov 13, 2026 | Filed with SEC | SEC EDGAR | |
| SYN2BIO Spółka Akcyjna | Biotech | Poland | terms not yet disclosed | Not yet set | Approved | ESMA | |
| Tarsier Pharma Ltd. | Pharmaceutical Preparations | — | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
| Windward Bio Group AG | Biological Products, (No Diagnostic Substances) | — | terms not yet disclosed | Not yet set | Filed with SEC | SEC EDGAR | |
6 companies have listed in the Biotech in the last 6 months. The most recent listing date on record is Oct 30, 2026. Listings span 2 exchanges: JPX, EURONEXT.
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
terms not yet disclosed
| Company | Industry | Country | Price range | Offer size | Listed | Status | Source |
|---|---|---|---|---|---|---|---|
| Aspen Neuroscience, Inc.ASPE | Pharmaceutical Preparations | United States | terms not yet disclosed | Oct 30, 2026 | Listed | SEC EDGAR | |
| Bambusa Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | United States | $16.00 | — | Oct 30, 2026 | Priced | SEC EDGAR |
| Encore Medical, Inc.EMI | Surgical & Medical Instruments & Apparatus | United States | terms not yet disclosed | Sep 28, 2026 | Listed | SEC EDGAR | |
| KOMPEITO Inc.618A | Biotech | Japan | ¥1,560 – ¥1,600 (~$10.40 – $10.67 USD) | — | Sep 11, 2026 | Listed | JPX |
| LAYERED Inc.634A | Biotech | Japan | terms not yet disclosed | Sep 25, 2026 | Listed | JPX | |
| OPTOPTS | Health Services | Italy | terms not yet disclosed | Jun 26, 2026 | Listed | Euronext | |
Get emailed when a new Biotech company files, prices, or lists — no weekly noise, just this sector.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy